A9555 HCPCS code: Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries
A9555 is the HCPCS Level II code for rubidium rb-82, diagnostic, per study dose, up to 60 millicuries. In 2024 Medicare paid an average of $419.82 per service for A9555 across 339,663 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 2 per day on outpatient hospital claims. Medicare volume rose 33% from 2022 to 2024 (256,002 to 339,663 services). In 2024, about 2,036 clinicians billed Medicare for A9555 for 207,157 beneficiaries; California, Florida, Texas accounted for 50% of services.
Code details
| Field | Value |
|---|---|
| Section | A codes — Transportation, medical/surgical supplies and miscellaneous |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 99 |
| BETOS category | I1E |
| Added | 2006-01-01 |
| Last action effective | 2006-01-01 |
Who bills A9555 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 2,036 |
| Medicare beneficiaries | 207,157 |
| States with claims | 41 |
| Share of services in top 3 states (California, Florida, Texas) | 50% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for A9555, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 256,002 | 158,109 | $527.20 | $420.78 |
| 2023 | 285,806 | 176,299 | $533.09 | $425.12 |
| 2024 | 339,663 | 207,157 | $526.63 | $419.82 |
States with the most A9555 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| California | 82,150 | $406.66 |
| Florida | 52,184 | $323.93 |
| Texas | 36,723 | $511.41 |
| Illinois | 29,416 | $545.62 |
| New York | 18,532 | $346.92 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 2 | Clinical: Data |
| practitioner claims | 2 | Clinical: Data |
Medicare policy articles for this code
- A56476: Billing and Coding: Cardiac Radionuclide Imaging (Palmetto GBA (MAC - Part A, MAC - Part B))
Covered diagnoses (632 ICD-10-CM codes)
The diagnoses most often listed as covered in the policy articles above:
| ICD-10-CM | Diagnosis | Articles listing it |
|---|---|---|
| A18.84 | Tuberculosis of heart | 1 |
| C58 | Malignant neoplasm of placenta | 1 |
| C81.10 | Nodular sclerosis Hodgkin lymphoma, unspecified site | 1 |
| C81.11 | Nodular sclerosis Hodgkin lymphoma, lymph nodes of head, face, and neck | 1 |
| C81.12 | Nodular sclerosis Hodgkin lymphoma, intrathoracic lymph nodes | 1 |
| C81.13 | Nodular sclerosis Hodgkin lymphoma, intra-abdominal lymph nodes | 1 |
| C81.14 | Nodular sclerosis Hodgkin lymphoma, lymph nodes of axilla and upper limb | 1 |
| C81.15 | Nodular sclerosis Hodgkin lymphoma, lymph nodes of inguinal region and lower limb | 1 |
| C81.16 | Nodular sclerosis Hodgkin lymphoma, intrapelvic lymph nodes | 1 |
| C81.17 | Nodular sclerosis Hodgkin lymphoma, spleen | 1 |
Showing 10 of 632. The full list, non-covered diagnoses and CSV export are in Caduvo.
What changed for A9555
- 2006-01-01: A9555 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code A9555?
A9555 is the HCPCS Level II code for rubidium rb-82, diagnostic, per study dose, up to 60 millicuries. Short descriptor: "Rb82 rubidium".
How much does Medicare pay for A9555?
In 2024, the average Medicare payment was $419.82 per service (average allowed $526.63).
Does Medicare cover A9555?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Which diagnoses support coverage for A9555?
Medicare policy articles that cite A9555 list 632 covered ICD-10-CM diagnosis codes across 1 article. The most cited include A18.84 (Tuberculosis of heart), C58 (Malignant neoplasm of placenta), C81.10 (Nodular sclerosis Hodgkin lymphoma, unspecified site). A listed diagnosis is necessary but not sufficient; the policy's other criteria still apply.
How many units of A9555 can be billed per day?
2 on outpatient hospital claims; 2 on practitioner claims (NCCI medically unlikely edits).
Related A95 codes
- A9500 — Technetium tc-99m sestamibi, diagnostic, per study dose
- A9501 — Technetium tc-99m teboroxime, diagnostic, per study dose
- A9502 — Technetium tc-99m tetrofosmin, diagnostic, per study dose
- A9503 — Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries
- A9504 — Technetium tc-99m apcitide, diagnostic, per study dose, up to 20 millicuries
- A9505 — Thallium tl-201 thallous chloride, diagnostic, per millicurie
- A9506 — Graphite crucible for preparation of technetium tc 99m-labeled carbon aerosol, one crucible
- A9507 — Indium in-111 capromab pendetide, diagnostic, per study dose, up to 10 millicuries
- A9508 — Iodine i-131 iobenguane sulfate, diagnostic, per 0.5 millicurie
- A9509 — Iodine i-123 sodium iodide, diagnostic, per millicurie
- A9510 — Technetium tc-99m disofenin, diagnostic, per study dose, up to 15 millicuries
- A9512 — Technetium tc-99m pertechnetate, diagnostic, per millicurie
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under A9555
- Watch A9555 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for A9555
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.